A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
Status:
Recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
This Phase 2 trial will evaluate the safety and efficacy of ABP-450 for the treatment of
cervical dystonia in adults. The study will enroll 60 patients across approximately 30 sites
in the United States. Study subjects will be divided evenly across a low dose group, a medium
dose group, a high dose group, and a placebo group for one treatment cycle.